Vir Biotechnology, Inc. Common Stock (VIR) is a publicly traded Healthcare sector company. As of July 23, 2026, VIR trades at $9.53 with a market cap of $1.59B and a P/E ratio of -3.00. VIR moved -0.85% today. Year to date, VIR is +55.06%; over the trailing twelve months it is +63.18%. Its 52-week range spans $4.16 to $14.45. Analyst consensus is strong buy with an average price target of $21.43. Rallies surfaces VIR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for VIR combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $9.53 |
| Market Cap | $1.59B |
| P/E Ratio | -3.00 |
| EPS | $-3.12 |
| Dividend Yield | 0.03% |
| 52-Week High | $14.45 |
| 52-Week Low | $4.16 |
| Volume | 1.24M |
| Avg Volume | 0 |
| Revenue (TTM) | $65.50M |
| Net Income | $-442.72M |
| Gross Margin | 0.00% |
9 analysts cover VIR: 0 strong buy, 9 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $21.43.